Global G-protein coupled receptors market to reach $4.76B by 2030 at 7% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The G-Protein Coupled Receptors Market Progress Between 2026 And 2030?

The g-protein coupled receptors market has experienced significant growth in recent years. It is projected to expand from $3.4 billion in 2025 to $3.63 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.8%. Historically, this market’s expansion was driven by the growth in neurotransmitter research, advancements in receptor biology, the broader expansion of pharmaceutical R&D, progress in cell line development, and innovation in assay technology.

The g-protein coupled receptors market size is projected for substantial expansion in the coming years, with an expectation to reach $4.77 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.0%. This anticipated growth during the forecast period can be attributed to several factors, including the increasing demand for precision drug targeting, advancements in AI-driven drug discovery, the expansion of the biologics pipeline, ongoing receptor deorphanization research, and rising investment in translational research. Furthermore, significant trends in this period involve the increasing adoption of GPCR targets in drug discovery, the broader implementation of high-throughput screening, a heightened focus on orphan receptor research, the evolution of cell-based assay technologies, and strengthened academic and pharmaceutical collaborations.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report

What Key Drivers Are Fueling The Growth Of The G-Protein Coupled Receptors Market?

The increasing incidence of cancer is projected to fuel the expansion of the G-protein-coupled receptors market moving ahead. Cancer is a disease characterized by the uncontrolled spread of abnormal cells that can invade nearby tissues. Additionally, cancer cells may disseminate throughout the body via the lymphatic and vascular systems. G-protein-coupled receptors (GPCRs) regulate fundamental cancer characteristics such as proliferative signaling, replicative immortality, evasion of growth suppressors, resistance to apoptosis, and the activation of invasion and metastasis. For example, the American Cancer Society, a US-based professional organization, reported in January 2023 that 1,958,310 new cancer cases were identified in the United States in 2023, an increase compared to the approximately 1.9 million new cases estimated for 2022. Consequently, the growing occurrence of cancer is a key factor driving the expansion of the G-protein-coupled receptors market.

What Are The Main Segments Within The G-Protein Coupled Receptors Market Segment Structure?

The g-protein coupled receptors market covered in this report is segmented –

1) By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands

2) By Assay: CAMP Functional Assays, Calcium Functional Assays, β-Arrestin Functional Assays, Radioligand Binding And GTPγS Functional Assays, Internalization Assays, Trafficking Assays

3) By Applications: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Other Applications

Subsegments:

1) By Cell Lines: GPCR-Expressing Cell Lines, Stable And Transient Cell Lines

2) By Detection Kits: ELISA Kits, High-Throughput Screening Kits, Reporter Gene Assays

3) By Cell Culture Reagents: Media And Supplements, Transfection Reagents, Growth Factors

4) By Ligands: Agonists, Antagonists, Inverse Agonists

What Trends Are Influencing The G-Protein Coupled Receptors Market?

Companies operating within the G-protein coupled receptors market are frequently pursuing Initial Public Offerings (IPOs), primarily to fund the creation of drugs that target G protein-coupled receptors (GPCRs). This strategy aims to accelerate research and development efforts, advance clinical trials, and introduce groundbreaking therapies for a variety of diseases, including cancer, neurological disorders, and metabolic conditions. The capital raised from these offerings is chiefly allocated to supporting the development of the company’s leading product candidates, which are focused on chronic metabolic and pulmonary diseases. More precisely, the funds are earmarked for progressing their glucagon-like peptide-1 receptor (GLP-1R) agonist program, designed to treat diabetes and obesity. For instance, in February 2023, US-based Structure Therapeutics Inc successfully completed its initial public offering (IPO), raising $161 million to further its work on G-protein coupled receptor (GPCR)-based therapeutics. The company offered 10,740,000 American depositary shares (ADSs) at $15.00 per ADS, a figure significantly higher than its initial projections. Trading of these shares commenced on the Nasdaq Global Market under the ticker symbol ‘GPCR’.

Who Are The Companies Participating In The G-Protein Coupled Receptors Market?

Major companies operating in the g-protein coupled receptors market are Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Daiichi Sankyo Company Limited, Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Structure Therapeutics, Septerna

Get The Full G-Protein Coupled Receptors Market Report:

https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report

Which Region Is The Top Contributor To The G-Protein Coupled Receptors Market By Share?

North America was the largest region in the G-protein coupled receptors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the g-protein coupled receptors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized G-Protein Coupled Receptors Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report

Browse Through More Reports Similar to the Global G-Protein Coupled Receptors Market 2026, By The Business Research Company

Muscarinic Acetylcholine Receptor Market Report 2026

https://www.thebusinessresearchcompany.com/report/muscarinic-acetylcholine-receptor-global-market-report

Glp 1 Receptor Agonist Market Report 2026

https://www.thebusinessresearchcompany.com/report/glp-1-receptor-agonist-global-market-report

Glucagon Like Peptide 1 Market Report 2026

https://www.thebusinessresearchcompany.com/report/glucagon-like-peptide-1-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795